Kilter Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Kilter Group's REGN Position: Q2 2026 in Review
Kilter Group increased its Regeneron Pharmaceuticals (REGN) stake by 7.7% in Q2 2026, buying an estimated $1.36K and bringing the position to 28 shares worth $17.5K. The position accounts for 0.01% of the portfolio, ranked #320.
Kilter Group first reported a position in REGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $20.1K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Kilter Group held 28 shares of Regeneron Pharmaceuticals worth $17.5K as of Q2 2026.
- Kilter Group bought 2 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.36K.
- Regeneron Pharmaceuticals made up 0.01% of Kilter Group's portfolio in Q2 2026, its #320 holding.
- Kilter Group first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- Kilter Group's Regeneron Pharmaceuticals position peaked at $20.1K in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.